Bempedoic acid
Esperion
[]
study finds esperion's nexletol cuts heart attack risk by 23% in statin-intolerant patients #acc23 $espr 
The latest global #pharma news, insights, analysis, and views providing you with an information edge.  FirstWord Pharma. Where people who know first, go first.